113 related articles for article (PubMed ID: 1665827)
41. Effects of ATP and bradykinin on endothelial cell Ca2+ homeostasis and formation of cGMP and prostacyclin.
Gosink EC; Forsberg EJ
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1620-9. PubMed ID: 8279522
[TBL] [Abstract][Full Text] [Related]
42. Hydrogen peroxide generation and its regulation in FRTL-5 and porcine thyroid cells.
Björkman U; Ekholm R
Endocrinology; 1992 Jan; 130(1):393-9. PubMed ID: 1309340
[TBL] [Abstract][Full Text] [Related]
43. Effects of thyroid-stimulating hormone, carbachol, norepinephrine, and adenosine 3',5'-monophosphate on polyphosphatidylinositol phosphate hydrolysis in dog thyroid slices.
Taguchi M; Field JB
Endocrinology; 1988 Oct; 123(4):2019-26. PubMed ID: 2843355
[TBL] [Abstract][Full Text] [Related]
44. Heterologous desensitization of opioid-stimulated Ca2+ increase by bradykinin or ATP in NG108-15 cells.
Chueh SH; Song SL; Liu TY
J Biol Chem; 1995 Jul; 270(28):16630-7. PubMed ID: 7622472
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of the G protein G11alpha prevents desensitization of Ca2+ response to thyrotropin-releasing hormone.
Novotný J; Krůsek J; Drmota T; Svoboda P
Life Sci; 1999; 65(9):889-900. PubMed ID: 10465349
[TBL] [Abstract][Full Text] [Related]
46. A phospholipase C inhibitor, U-73122, blocks TSH-induced inositol trisphosphate production, Ca2+ increase and arachidonic acid release in FRTL-5 thyroid cells.
Wang XD; Kiang JG; Smallridge RC
Biochim Biophys Acta; 1994 Aug; 1223(1):101-6. PubMed ID: 8061042
[TBL] [Abstract][Full Text] [Related]
47. Ca(2+)-binding protein expression in primary human thyrocytes.
Lorenz S; Aust G; Krohn K
Biochim Biophys Acta; 2013 Dec; 1833(12):2703-2713. PubMed ID: 23886630
[TBL] [Abstract][Full Text] [Related]
48. Thyrotropin-induced hydrogen peroxide production in FRTL-5 thyroid cells is mediated not by adenosine 3',5'-monophosphate, but by Ca2+ signaling followed by phospholipase-A2 activation and potentiated by an adenosine derivative.
Kimura T; Okajima F; Sho K; Kobayashi I; Kondo Y
Endocrinology; 1995 Jan; 136(1):116-23. PubMed ID: 7828520
[TBL] [Abstract][Full Text] [Related]
49. Modulation of bradykinin-induced inositol trisphosphate release in a novel neuroblastoma x dorsal root ganglion sensory neuron cell line (F-11).
Francel PC; Miller RJ; Dawson G
J Neurochem; 1987 May; 48(5):1632-9. PubMed ID: 3494104
[TBL] [Abstract][Full Text] [Related]
50. Inositol phosphates and intracellular calcium after bradykinin stimulation in fibroblasts from young, normal aged and Alzheimer donors.
Huang HM; Toral-Barza L; Thaler H; Tofel-Grehl B; Gibson GE
Neurobiol Aging; 1991; 12(5):469-73. PubMed ID: 1770982
[TBL] [Abstract][Full Text] [Related]
51. Formation of inositol phosphate isomers in GH3 pituitary tumour cells stimulated with thyrotropin-releasing hormone. Acute effects of lithium ions.
Hughes PJ; Drummond AH
Biochem J; 1987 Dec; 248(2):463-70. PubMed ID: 3124813
[TBL] [Abstract][Full Text] [Related]
52. Effects of thyrotropin-releasing hormone on phosphoinositides and cytoplasmic free calcium in thyrotropic pituitary cells.
Brenner-Gati L; Gershengorn MC
Endocrinology; 1986 Jan; 118(1):163-9. PubMed ID: 3000732
[TBL] [Abstract][Full Text] [Related]
53. Thyrotropin-releasing hormone-stimulated inositol trisphosphate formation is liable to thyrotropin-releasing hormone-induced desensitization by a calcium-dependent mechanism.
Torjesen PA; Bjøro T; Ostberg BC; Haug E
Mol Cell Endocrinol; 1988 Mar; 56(1-2):107-14. PubMed ID: 3131167
[TBL] [Abstract][Full Text] [Related]
54. Physiological concentrations of thyrotropin increase cytosolic calcium levels in primary cultures of human thyroid cells.
D'Arcangelo D; Silletta MG; Di Francesco AL; Bonfitto N; Di Cerbo A; Falasca M; Corda D
J Clin Endocrinol Metab; 1995 Apr; 80(4):1136-43. PubMed ID: 7714082
[TBL] [Abstract][Full Text] [Related]
55. Calcium mobilization by inositol 1,4,5-trisphosphate during activation of islet, pituitary, and myeloid cells.
Wollheim CB; Biden TJ; Lew PD; Schlegel W
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S65-70. PubMed ID: 2433529
[TBL] [Abstract][Full Text] [Related]
56. Stimulation of inositol incorporation into lipids of PC12 cells by nerve growth factor and bradykinin.
Volonté C; Parries GS; Racker E
J Neurochem; 1988 Oct; 51(4):1156-62. PubMed ID: 2843607
[TBL] [Abstract][Full Text] [Related]
57. Thyrotropin-releasing hormone reduces myo-inositol content in rat cerebellum pretreated with lithium.
Miyamoto Y; Kikkawa R; Hatanaka I; Yasuda H; Terada M; Yamashita M; Shigeta Y
J Neurochem; 1987 Jul; 49(1):88-91. PubMed ID: 3035101
[TBL] [Abstract][Full Text] [Related]
58. Potentiation by gamma-aminobutyric acid of alpha 1-agonist-induced accumulation of inositol phosphates in slices of rat cerebral cortex.
Crawford ML; Young JM
J Neurochem; 1990 Jun; 54(6):2100-9. PubMed ID: 1971011
[TBL] [Abstract][Full Text] [Related]
59. Late-phase accumulation of inositol phosphates stimulated by prostaglandins D2 and F2 alpha in neuroblastoma x glioma hybrid NG108-15 cells.
Hatanaka M; Yumoto N; Miwa N; Morii H; Tanemura M; Ueno R; Watanabe Y; Hayaishi O
J Neurochem; 1989 Nov; 53(5):1450-5. PubMed ID: 2507741
[TBL] [Abstract][Full Text] [Related]
60. Thyroid-stimulating hormone stimulates increases in inositol phosphates as well as cyclic AMP in the FRTL-5 rat thyroid cell line.
Field JB; Ealey PA; Marshall NJ; Cockcroft S
Biochem J; 1987 Nov; 247(3):519-24. PubMed ID: 2827631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
